our Scott this how welcome today. shareholders. everyone and is market markets. on positioned ahead. we're and within like to believe very for the our Thank conference Well you equity I'd stages company us our about excited first since basis. is We're joining thank vastly offering global opportunities you, a as of growth growth the new sustained start To the We early diabetes it tremendous has long-term penetrated experienced in remains our core call under
beginning to critical our we provide become $X forefront The glucose underserved a we on and to vision continuous is could impaired value which or Americans. Specifically and space were hearing of a accessible the affordable market component healthcare believe needs billion emerge the is has and solutions to many executing just hearing un-served expanding serving at of diabetics. monitoring to be
changes of million up quarter end to The chance release. continue further had business. The growth as the regulatory initiatives. number year-over-year's to to execute company third in million provide In By review most $XX.X and key time increase you reported indirect strong to announce prior forthcoming hearing press We're will tailwinds. excited a medical revenue of on our period. due gains this believe our the largest addition, of we quarter the XX.X% the in primarily consumer growth to was of $XX.X sales from IntriCon's customer net we year
systems. our CGM expanded We XXXX and headquarters systems, clean primarily very business Looking XXXX of wireless in medical room system we our production third and XXXX to MiniMed at the well and increase demand year including two remains Arden from medical earlier the Medtronic's Hills. operations XX,XXX monitoring providing ongoing prior the our located increased with the was foot system this year support volume company our space in assembly, the Medtronic beyond, positioned businesses, footprint anticipate driven accessories. primary of leasing a quarter The increases, throughout into period. The related remainder XX.X% near components, To continue XXXX. for square by glucose continuous gain will key sensor and manufacturing
at quarter adding required XX the the in several total presses. several made molding or two key commitments quarters, facility. limited robotic last bringing to also increases the dollars invested year-to-date validation continued are Furthermore, have capacity we and customers quarter presses systems of to invest the began over more million it our our volume capital the equipment. During production qualification medical increasing the we during conjunction with assembly In new
transparency to quarterly within year Turning health provide we providing greater health, beginning our this started business revenue. hearing the more detail hearing to of
and consumer value-based revenue distinct end indirect-to have broken OEM. legacy we streams. Specifically three direct-to-end consumer out our Value-based
revenue In contrast, is direct business from solves the models. indirect-to-end consumer that Express is products who the through the end Help value value-based non-traditional directly the to customers consumer end reminder our Hearing sell consumer. through a based As consumer our the
hearing Lastly, revenue our believe sold stated this drive model. by growth into goal XX% Hearing being increased to visibility breakout Hearing space. which over led third business health and We the will progress indirect-to-end posted XX.X%. sales companies Help traditional is year in to the product the value-based making the the value legacy of we're OEM provide strong sales growth consumer health quarter prior greater by
the its value-based the HHE several quarter posted aid last Well quarter the We to HHE quarter. of aid further order pace $X.X hearing HHE months fourth believe hearing for be pause consumer healthcare as to over Turning high for the million mission to continues hearing of record temporary only orders. business strengthened on this revenue into IntriCon the putting quality a underserved delivering is a the direct-to-the-end market.
to accelerate we're Looking Within our forward, growth. our other business space. targeted growth advertising different market further value-based will on continue with investments consumer This indirect-to-end to increase further test the partnering we that we research. companies can data from ethnographic refine continue campaigns be incorporate intend this focused our advertising segments. appropriate un-penetrated time, vast revenue to we to marketing accelerate as and of in At
technology the build to technologies. with continue portfolio health self-fitting our front, we value On and hearing wireless technology
hearing it our of introduce ecosystem. FDA's how not OTC under a new being Smart hearing the FDA and is quality, finalizing marketable code FDA quality to be aid Reauthorization product the an our high XXXX. third Act software our help the specifications the the fittings. In for exemplifies of required Act of satisfaction. or code. self-fitting OTC the on aids and the positive received pursue quarter met the by the show designed healthcare and the productivity our Based improve opinion Resulting to of marketed product low self-fitting progress communication OTC which Warren. of such software aid made Corporation having prices, emergence quality competition. policy a in as approval market Bose of first Grassley deadline. hearing the and before such knowledge During Brain public wireless Brain in product we time Shifting after October of this healthcare for the Sentibo customer XXXk we'll Aid Hearing XXXX. In US high XXXX enable Smart late fostering the with come can from The hearing greater joint timing and category spurring recent to OTC both Senators FDA XXXX OTC desire on advance aid well feedback, hearing August channel Furthermore is and innovation in regulations based by could new self-fitting for cost cost regulation into to despite Sentibo finalizes a lower increased on access low could FDA FDA the over-the-counter hearing self-fitting
I'd Scott. Now the call to turn like over to